According to a regulatory filing by Strides Pharma Science, previous HDFC Bank managing director Aditya Puri has joined international pharma company Strides Group as an advisor. He will also work as a director of its subordinate company Stelis Biopharma. As per Strides Pharma Science, Puri’s appointment to the Stelis board comes at an exhilarating stage for the company. This is because the company is transitioning from its development phase to a consolidation and growth phase. It is working to cement itself as a partner of choice globally with the objective of offering world-class treatments at reasonable costs to patients in both developing and advanced markets.
Puri, on his appointment, stated that the Stride Group’s global success and headstart in terms of basic infrastructure and established parentage offers him the opportunity to be a part of and mentor Stelis and other Group efforts in their thrilling growth story. The founder and chairman of the Board of Strides – Arun Kumar – expressed his happiness and welcomed Puri as his advisor. Since the inception of HDFC Bank, Puri was the one who led the bank for more than 25 years. After a successful career, he retired in October 2020. His leadership led the bank to become the largest private bank.
In the early 1990s, he was heading a foreign bank’s operations in Malaysia. He got an offer from Deepak Parekh of HDFC to return to India to run a bank. At that point of time, Indian economy had shifted gears with liberalisation moves. Apart from this, US-based global investment firm Carlyle Group had also approached Puri in November 2020.